Do we correctly calculate doses of cardioplegia during aortic valve replacement procedures? A preliminary report

Aleksandra Sucharska1, Agnieszka Adamowska1, Zuzanna Karbowska1

  • 1Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, Poznan, Poland.

Insights

Optimizing cardioplegia volume indexed for left ventricular mass during aortic valve replacement improves myocardial protection and long-term survival. Standard body mass calculations may be insufficient for effective patient outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Cardiopulmonary Bypass

Background:

  • Intraoperative myocardial protection is critical for successful aortic valve replacement (AVR) in patients with aortic stenosis (AS).
  • Current cardioplegia dosing often relies on patient body mass, a method whose universal applicability is questioned.

Purpose of the Study:

  • To evaluate whether standard body mass-based cardioplegia dosing is optimal for all AS patients undergoing AVR.
  • To investigate the relationship between indexed cardioplegia volume, myocardial injury, and long-term survival after AVR.

Main Methods:

  • Ninety-four patients undergoing elective isolated AVR with cold cardioplegic arrest were studied.
  • Patients were divided into high (above median) and low (below median) cardioplegia volume groups, indexed for left ventricular mass (LVM).
  • Myocardial injury was assessed by maximal postoperative cardiac troponin I (cTnI max) release; long-term survival was analyzed using Kaplan-Meier methods.

Main Results:

  • Higher indexed cardioplegia volumes correlated with lower cTnI max levels (r = 0.345).
  • Group A (high cardioplegia volume) exhibited significantly lower cTnI max compared to Group B (low volume) (medians: 14.918 vs. 9.876 μg/l; p = 0.005).
  • Five-year survival was significantly better in the high-volume group (95.7%) versus the low-volume group (82.6%; p = 0.044).

Conclusions:

  • Relying solely on body mass for cardioplegia dosing in AVR may be suboptimal.
  • Adjusting cardioplegia volume indexed to left ventricular mass can enhance myocardial protection.
  • Optimized cardioplegia strategies significantly impact postoperative outcomes and long-term survival in AS patients undergoing AVR.
Abstract